Published in
Elsevier, EClinicalMedicine, (54), p. 101691, 2022
DOI: 10.1016/j.eclinm.2022.101691
Links
Tools
Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
Journal article published in 2022 by
Linong Ji,
Leili Gao,
Hongwei Jiang,
Jing Yang,
Lei Yu,
Jie Wen,
Chenghang Cai,
Huan Deng,
Liqi Feng,
Baili Song,
Qingyang Ma 
,
Lei Qian
,
Lei Qian
This paper is made freely available by the publisher.
Full text: Download
Data provided by 